Current Practice in Evaluation of Treatment Interventions for Individuals with Chronic Diseases

February 15, 2007 Current Practice in Evaluation of Treatment Interventions for Individuals with Chronic Diseases What questions can we answer about new neurotechnology devices designed for treating patients with depression? What is the evidence needed to allow access to these new treatment methodologies to patients with no other treatment options - at a minimum the 33% of patients in the STAR*D trial that did not reach remission. In her presentation to the National Task Force on Consumer Access to Emerging Neurotechnologies, Susan Horn, Ph.D., Senior Scientist, Institute for Clinical Outcomes Research & Vice President, Research, International Severity Information Systems . . .